Menu

Matthew focuses his practice representing issuers and underwriters in a range of capital markets transactions including initial public offerings, follow-on offerings, registered direct offerings, PIPEs and ATM offerings. Matthew also regularly advises public companies on general corporate matters, including SEC reporting and corporate governance.

Download full bio 

Experience

  • Seabridge Gold – $105.2 Million Follow-on Offering 

  • Verve Therapeutics – $258.8 Million Follow-on Offering 

  • Verve Therapeutics – $258.8 Million Follow-on Offering 

  • EyePoint Pharmaceuticals – $115.4 Million Follow-on Offering 

  • Crinetics Pharmaceuticals – $125 Million Follow-On Offering 

  • View all

Education

  • George Washington University Law School
    JD, 2019

  • University of Connecticut
    BA, Political Science and French
    summa cum laude, 2016


Admissions & Credentials

New York